Regarding mobile health applications, the majority of the patients with diabetes studied used them for blood glucose monitoring (93.4%), physical activity programs (44.3%) and nutritional programs (39.3%), and a few of them used applications for insulin dose determination (3.3%). The gene discussed is INS; the disease is diabetes mellitus.